Resultados de procura - Navdeep Pal

  • Mostrando 1 - 8 Resultados de 8
Limitar resultados
  1. 1
    Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting

    Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting por Cristina Julián, Navdeep Pal, Anda Gershon, Marie Evangelista, Hans E. Purkey, Peter Lambert, Zhen Shi, Qing Zhang

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Overall survival after pelvic exenteration for gynecologic malignancy

    Overall survival after pelvic exenteration for gynecologic malignancy por Shannon N. Westin, Vijayashri Rallapalli, Bryan Fellman, Diana L. Urbauer, Navdeep Pal, Michael Frumovitz, Lois M. Ramondetta, Diane C. Bodurka, Pedro T. Ramírez, Pamela T. Soliman

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Evaluating eligibility criteria of oncology trials using real-world data and AI

    Evaluating eligibility criteria of oncology trials using real-world data and AI por Ruishan Liu, Shemra Rizzo, Samuel Whipple, Navdeep Pal, Arturo López Pineda, Michael W. Lu, Brandon Arnieri, Ying Lü, William B. Capra, Ryan Copping, James Zou

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data

    Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-hig... por M. Pérol, Enriqueta Felip, Urania Dafni, Letizia Polito, Navdeep Pal, Zoi Tsourti, Thanh G.N. Ton, David M. Merritt, S. Morris, Rolf A. Stahel, Solange Peters

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patients

    Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patients por Ruishan Liu, Lisa Wang, Shemra Rizzo, Marius Garmhausen, Navdeep Pal, Sarah Waliany, Sarah F. McGough, Yvonne G. Lin, Zhi Huang, Joel W. Neal, Ryan Copping, James Zou

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device

    Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device por Navdeep Pal, Russell R. Broaddus, Diana L. Urbauer, Nyla Balakrishnan, Andrea Milbourne, Kathleen M. Schmeler, Larissa A. Meyer, Pamela T. Soliman, Karen H. Lu, Pedro T. Ramírez, Lois M. Ramondetta, Diane C. Bodurka, Shannon N. Westin

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients

    PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients por Shannon N. Westin, Zhenlin Ju, Russell R. Broaddus, Camilla Krakstad, Jane Li, Navdeep Pal, Karen H. Lu, Robert L. Coleman, Bryan T. Hennessy, Samuel J. Klempner, Henrica M.J. Werner, Helga B. Salvesen, Lewis C. Cantley, Gordon B. Mills, Andrea P. Myers

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer

    Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer por Shannon N. Westin, Bryan Fellman, Charlotte C. Sun, Russell R. Broaddus, Misty Woodall, Navdeep Pal, Diana L. Urbauer, Lois M. Ramondetta, Kathleen M. Schmeler, Pamela T. Soliman, Nicole D. Fleming, Jennifer K. Burzawa, Alpa M. Nick, Andrea Milbourne, Ying Yuan, Karen H. Lu, Diane C. Bodurka, Robert L. Coleman, Melinda S. Yates

    Publicado 2020
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: